Outlook Therapeutics, Inc.
NASDAQ:OTLK
1.47 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||
Current Assets: | ||||||||||
Cash & Cash Equivalents
| 23.392 | 17.397 | 14.477 | 12.536 | 8.016 | 1.717 | 3.186 | 2.352 | 2.349 | 9.071 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 23.392 | 17.397 | 14.477 | 12.536 | 8.016 | 1.717 | 3.186 | 2.352 | 2.349 | 9.071 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.3 | 4.3 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
Other Current Assets
| 7.587 | 10.124 | 7.031 | 4.608 | 5.486 | 1.185 | 0.2 | 1.347 | 1.793 | 1.793 |
Total Current Assets
| 30.979 | 27.52 | 21.508 | 17.944 | 13.502 | 3.302 | 3.905 | 5.678 | 3.147 | 15.164 |
Non-Current Assets: | ||||||||||
Property, Plant & Equipment, Net
| 0.026 | 0.07 | 0.275 | 0.494 | 3.176 | 18.49 | 16.089 | 16.959 | 8.01 | 17.76 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0.794 | 0.805 | 0.854 | 0.9 | 0 | 0 | 0 | 0.216 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.501 | 0.132 | 0.175 | 0.394 | 0.457 | 0.491 | 0.74 | 0.853 | 0.448 | 2.084 |
Total Non-Current Assets
| 1.321 | 1.007 | 1.303 | 1.789 | 3.633 | 18.981 | 16.829 | 18.027 | 8.457 | 19.844 |
Total Assets
| 32.301 | 28.528 | 22.811 | 19.733 | 17.135 | 22.283 | 20.734 | 23.706 | 11.604 | 35.009 |
Liabilities & Equity: | ||||||||||
Current Liabilities: | ||||||||||
Account Payables
| 6.575 | 3.491 | 2.196 | 2.395 | 2.278 | 3.61 | 10.954 | 5.072 | 11.563 | 11.563 |
Short Term Debt
| 35.555 | 10.954 | 0.974 | 7.851 | 11.53 | 18.379 | 5.006 | 6.176 | 15.82 | 15.82 |
Tax Payables
| 1.857 | 1.857 | 1.857 | 1.857 | 1.859 | 1.856 | 2.352 | 1.855 | 1.564 | 1.755 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 1.739 | 3.088 | 1.213 | 1.501 | 1.98 |
Other Current Liabilities
| 2.746 | 3.428 | 1.726 | 3.786 | 4.623 | 6.458 | 7.337 | 6.122 | -8.737 | 5.925 |
Total Current Liabilities
| 46.732 | 19.73 | 6.752 | 15.889 | 20.29 | 32.042 | 28.738 | 20.437 | 20.21 | 37.042 |
Non-Current Liabilities: | ||||||||||
Long Term Debt
| 0 | 0.004 | 10.929 | 0.947 | 3.416 | 3.552 | 13.411 | 2.555 | 6.142 | 6.142 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 2.758 | 4.467 | 5.153 | 6.313 | 6.366 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 3.453 | 2.275 | 0 | 4.659 | 14.43 |
Other Non-Current Liabilities
| 0.006 | 0.057 | 0.523 | 0.071 | 4.199 | 4.742 | 4.845 | 0.761 | 2.434 | 0.285 |
Total Non-Current Liabilities
| 0.006 | 0.061 | 11.452 | 1.018 | 7.615 | 11.052 | 22.723 | 8.469 | 14.942 | 27.223 |
Total Liabilities
| 46.738 | 19.791 | 18.204 | 16.907 | 27.905 | 43.094 | 51.46 | 28.906 | 35.152 | 64.265 |
Equity: | ||||||||||
Preferred Stock
| 0 | 28,527,751 | 22,811,451 | 19,732,551 | 5.359 | 4.734 | 2.924 | 23,705,934 | 9.378 | 10.191 |
Common Stock
| 2.603 | 2.273 | 1.765 | 1.272 | 0.286 | 0.722 | 0.249 | 0.228 | 0.04 | 39.845 |
Retained Earnings
| -467.918 | -408.936 | -342.883 | -289.72 | -254.48 | -216.307 | -186.215 | -147.394 | -45.151 | -94.064 |
Accumulated Other Comprehensive Income/Loss
| 0 | 417.672 | -22,811,451 | -19,732,551 | 238.351 | 190.762 | -8.645 | -5.962 | -1.819 | -3.643 |
Other Total Stockholders Equity
| 450.878 | -28,527,335.601 | 345.726 | 291.274 | 238.065 | 190.672 | 152.315 | -23,705,792.007 | 15.427 | 19.07 |
Total Shareholders Equity
| -14.438 | 8.737 | 4.607 | 2.826 | -10.77 | -20.811 | -30.727 | -5.2 | -23.548 | -28.602 |
Total Equity
| -14.438 | 8.737 | 4.607 | 2.826 | -10.77 | -20.811 | -30.727 | -5.2 | -23.547 | -29.256 |
Total Liabilities & Shareholders Equity
| 32.301 | 28.528 | 22.811 | 19.733 | 17.135 | 22.283 | 20.734 | 23.706 | 11.604 | 35.009 |